GlassScriptPhysician profile
Mary See
NPI 1316939150
$1,467.48
in general payments reported to CMS, 2019-2025
20 companies · $312 in 2025
The $312 reported for 2025 was more than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $50.06 · 2021: $13.50 · 2022: $142 · 2023: $271 · 2024: $563 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,146.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $250.80 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $190.33 | 2022-2025 | Gattex |
| Azurity Pharmaceuticals, INC. | $163.06 | 2023-2024 | Triptodur, Triptodur |
| Cumberland Pharmaceuticals, INC. | $139.76 | 2019-2023 | Kristalose |
| Regeneron Healthcare Solutions, INC. | $121.04 | 2023-2025 | Dupixent |
| Qol Medical, LLC | $110.19 | 2025 | Sucraid |
| Janssen Biotech, INC. | $84.54 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $61.44 | 2019-2024 | Strensiq |
| Ascendis Pharma Endocrinology INC | $57.79 | 2024 | |
| Endo USA, INC. | $39.44 | 2024 | Supprelin |
| Nestle Healthcare Nutrition INC. | $31.57 | 2023 | |
| Avanos Medical | $30.08 | 2020 | |
| Amneal Pharmaceuticals LLC | $26.49 | 2024 | Unithroid |
| Celltrion USA INC. | $25.11 | 2024 | Vegzelma |
| Biocon Biologics INC | $24.61 | 2024 | Hulio |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $23.62 | 2022 | |
| Abbott Laboratories | $23.40 | 2024 | Freestyle Libre |
| Biomarin Pharmaceutical INC. | $22.55 | 2024 | Voxzogo 1.2mg |
| Travere Therapeutics, INC. | $21.47 | 2023 | Cholbam |
| Endo Pharmaceuticals INC. | $20.19 | 2024 | Supprelin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary See listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.